Il retinoblastoma

Translated title of the contribution: Retinoblastoma

Alfonso D'ambrosio, Gianni Coriolani, Mauro Caini, Daniela Galimberti, Sara Giomi, Silvia Badii, Silvia Moretti, Maria Stefania Toti, Francesca Coccina, Federica Carra, Theodora Hadjistilianou

Research output: Contribution to journalArticle

Abstract

Retinoblastoma is the most frequently diagnosed intraocular malignancy in infants. Recently, there have been significant advances in the management of this disease. New therapeutic strategies, such as superselective intra-arterial chemotherapy and periocular/intravitreal chemotherapy, have been added to conservative treatments with a long consolidated efficacy. All these procedures are available at the Referral Centre for Retinoblastoma of the University Hospital of Siena. These advances have been reflected in increased rates of eye salvage and improved visual outcomes, notwithstanding the primary objective to safeguard the lives of affected children. This article summarizes the most important clinical and therapeutic aspects of this malignancy that every paediatrician should be aware of, particularly when retinoblastoma is suspected in a young patient.

Original languageItalian
Pages (from-to)227-236
Number of pages10
JournalMedico e Bambino
Volume32
Issue number4
Publication statusPublished - Apr 2013

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

D'ambrosio, A., Coriolani, G., Caini, M., Galimberti, D., Giomi, S., Badii, S., Moretti, S., Toti, M. S., Coccina, F., Carra, F., & Hadjistilianou, T. (2013). Il retinoblastoma. Medico e Bambino, 32(4), 227-236.